Package 0591-0395-00

{"spl_id": "51abfbe5-cccf-4e8a-8600-19890c3b50fb", "openfda": {}, "finished": false, "packaging": [{"description": "45460 TABLET in 1 BOX (0591-0395-00)", "package_ndc": "0591-0395-00", "marketing_start_date": "16-SEP-15"}, {"description": "54552 TABLET in 1 CONTAINER (0591-0395-77)", "package_ndc": "0591-0395-77", "marketing_start_date": "16-SEP-24"}], "product_id": "0591-0395_51abfbe5-cccf-4e8a-8600-19890c3b50fb", "dosage_form": "TABLET", "product_ndc": "0591-0395", "dea_schedule": "CIV", "generic_name": "Pentazocine Hydrochloride and Naloxone Hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".5 mg/1"}, {"name": "PENTAZOCINE HYDROCHLORIDE", "strength": "50 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20150916", "listing_expiration_date": "20261231"}